Discussion on Malaria Drug and Vaccines

I'll just speak for myself.

It's been out for a long time.

It's a malaria drug.

It's also a drug for lupus.

And there's a there's a study out that

people with lupus aren't catching this horrible virus

and not they're not affected so much by it.

Now, maybe that's correct. Maybe it's false.

You're going to have to check it out.

But there's a lot of very positive things happening with that.

That's a game changer if that's the case.

Obviously, we continue to work on the vaccines,

but the vaccines have to be down the road

by probably 14, 15, 16 months.

We're doing great on the vaccines.

I think Johnson and Johnson is leading.

It seems to be leading in terms of the studies,

but we'll see what happens.

But I feel good about that.

But that's down the road.

But tremendous promise with with what's just been mentioned.

In addition to that,

Gilead Sciences has initiated a phase three.

That's down the line, meaning clinical studies of the drug remdesivir.

Now, it's approximately 1000 patients,

which is a pretty, pretty good study.